Patients with elevated atherosclerotic CVD and kidney failure risks may never have received a nephrology referral, according ...
Patients with Medicare Advantage plans may have lower odds of receiving a kidney transplant referral than patients with ...
Vascular access type and other factors may be associated with depression severity for patients on hemodialysis, according to ...
Perceived and objective understandings of AKI and related risks may be low among patients who had AKI during hospitalization, ...
Infectious disease experts on Thursday criticized U.S. health officials’ response to the hantavirus outbreak that killed ...
With several new therapies, extensive research and critical trials underway, nephrology is in a “golden age,” according to ...
Myopia progressed more slowly across 2 years in children wearing Acuvue Abiliti 1-Day daily disposable contact lenses, ...
Published results showed patients who received a higher number of corticosteroid injections before total shoulder ...
The National Kidney Foundation Spring Clinical Meetings opened with presentations on the latest innovations and wins in the ...
The FDA has approved zenocutuzumab-zbco as the first drug for certain patients with a rare and aggressive bile duct cancer.
The FDA has approved IV ocrelizumab for treatment of relapsing-remitting MS in children and adolescents aged 10 years and ...
Glaucoma and hypertension were both linked with worsened cognitive performance, according to a poster presentation at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results